Are you an adult in the US currently using an FDA-approved weekly GLP-1 medication for weight management? You may be eligible to participate in a research study.

Bridge Access Solutions (BAS) is conducting a research study with individuals currently prescribed and taking a GLP-1 medication to gain insight into real-world participant experiences and to identify unmet needs.

  • What’s Involved: Completion of an electronic, 8–10-minute daily diary over a period of 6 weeks. You will be asked questions about your experience with some side effects (nausea, vomiting and diarrhea) and food/appetite, relative to your weekly GLP-1 dose.
  • Eligibility: 18+ US adults with a BMI of 30 or greater (when you started treatment), currently using a GLP-1 medication without diabetes.
  • When: Enrollment begins mid-March 2026.
  • Privacy: Your feedback will be de-identified, and reasonable steps will be taken to protect your privacy. If you qualify and choose to participate, you may be asked to authorize access to relevant medical records.

{{ failureMessage }}

  If you are interested, complete our online screener.

{{ errors.email[0] }}
<strong>Are you an adult in the US currently using an FDA-approved weekly GLP-1 medication for weight management? You may be eligible to participate in a research study.</strong>
Participate in a Paid Research Study To Understand Your Experience with Weekly GLP-1 Medications for Weight Management

Participant Benefits

Compensation: $125 upon study completion.
loading...